Identification of the critical features of a small peptide inhibitor of JNK activity

被引:194
作者
Barr, RK
Kendrick, TS
Bogoyevitch, MA
机构
[1] Univ Western Australia, Cell Signaling Lab, Dept Biochem, Crawley, WA 6009, Australia
[2] Western Australian Inst Med Res, Perth, WA 6000, Australia
关键词
D O I
10.1074/jbc.M107565200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The c-Jun N-terminal kinases (JNKs) are a subfamily of the mitogen-activated protein kinases (NLAPKs). Although progress in evaluating the functions of other MAPKs has been facilitated by the characterization of specific inhibitors, no JNK-directed inhibitor is commercially available. We have identified a 21-amino acid peptide inhibitor of activated JNKs, based on amino acids 143-163 of the JNK-binding domain (JBD) of the JNK scaffolding protein, JNK-interacting protein-1 (JIP-1). This peptide, I-JIP (Inhibitor of JNK-based on JIP-1), inhibited JNK activity in vitro toward recombinant c-Jun, Elk, and ATF2 up to 90%. A truncated I-JIP (TI-JIP), the C-terminal 11 amino acids of I-JIP, directly interacted with recombinant JNKs but not its substrates as shown by surface plasmon resonance analysis. Scanning alanine replacement within truncated I-JIP identified 4 residues (Arg-156, Pro-157, Leu-160, or Leu-162) as independently critical for inhibition. JBD peptide sequences from JIP-2 and JIP-3 shared these critical residues and accordingly were effective JNK inhibitors. In contrast, peptides based on the JBDs of ATF2 and c-Jun inhibited JNK activity by <40%, which agreed with their lack of homology to the critical Arg-156 and Pro-157. These studies thus define a small peptide inhibitor sequence of JNKs based on the JIP proteins.
引用
收藏
页码:10987 / 10997
页数:11
相关论文
共 45 条
  • [31] Maroney AC, 1999, J NEUROCHEM, V73, P1901
  • [32] CEP-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
    Maroney, AC
    Finn, JP
    Connors, TJ
    Durkin, JT
    Angeles, T
    Gessner, G
    Xu, ZH
    Meyer, SL
    Savage, MJ
    Greene, LA
    Scott, RW
    Vaught, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) : 25302 - 25308
  • [33] Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics
    Monaco, R
    Friedman, FK
    Hyde, MJ
    Chen, JM
    Manolatus, S
    Adler, V
    Ronai, Z
    Koslosky, W
    Pincus, MR
    [J]. JOURNAL OF PROTEIN CHEMISTRY, 1999, 18 (08): : 859 - 866
  • [34] A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1β-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology
    Ng, DCH
    Long, CS
    Bogoyevitch, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) : 29490 - 29498
  • [35] Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components
    Nihalani, D
    Meyer, D
    Pajni, S
    Holzman, LB
    [J]. EMBO JOURNAL, 2001, 20 (13) : 3447 - 3458
  • [36] Biosensor-based estimation of kinetic and equilibrium constants
    Quinn, JG
    O'Kennedy, R
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 290 (01) : 36 - 46
  • [37] Protein transduction: unrestricted delivery into all cells?
    Schwarze, SR
    Hruska, KA
    Dowdy, SF
    [J]. TRENDS IN CELL BIOLOGY, 2000, 10 (07) : 290 - 295
  • [38] TANG SH, 1998, EMBO J, V17, P1740
  • [39] Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation
    Turkson, J
    Ryan, D
    Kim, JS
    Zhang, Y
    Chen, Z
    Haura, E
    Laudano, A
    Sebti, S
    Hamilton, AD
    Jove, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) : 45443 - 45455
  • [40] Vincenti MP, 2001, J CLIN INVEST, V108, P181